Chunyan Zhao

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CANCER LETTERS. 2021;506:23-34
Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor
Song D; He H; Sinha I; Hases L; Yan F; Archer A; Haldosen L-A; Zhao C; Williams C
Article: ONCOGENE. 2019;38(28):5725-5738
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1
He H; Song D; Sinha I; Hessling B; Li X; Haldosen L-A; Zhao C
Article: ONCOGENE. 2018;37(19):2586-2600
c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer
He H; Sinha I; Fan R; Haldosen L-A; Yan F; Zhao C; Dahlman-Wright K
Article: ONCOTARGET. 2016;7(44):71580-71593
Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells
Diao Y; Azatyan A; Rahman MF-U; Zhao C; Zhu J; Dahlman-Wright K; Zaphiropoulos PG
Article: CANCER RESEARCH. 2016;76(19):5634-5646
Estrogen Receptor a Promotes Breast Cancer by Reprogramming Choline Metabolism
Jia M; Andreassen T; Jensen L; Bathen TF; Sinha I; Gao H; Zhao C; Haldosen L-A; Cao Y; Girnita L; Moestue SA; Dahlman-Wright K
Article: ONCOGENE. 2016;35(15):1955-1964
RING finger protein 31 promotes p53 degradation in breast cancer cells
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Stromblad S; Dahlman-Wright K
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2016;291(10):5068-5079
AP-1 Is a Key Regulator of Proinflammatory Cytokine TNF α-mediated Triple-negative Breast Cancer Progression
Qiao Y; He H; Jonsson P; Sinha I; Zhao C; Dahlman-Wright K
Article: ONCOTARGET. 2015;6(41):43853-43868
p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells
Zhuang T; Zhu J; Li Z; Lorent J; Zhao C; Dahlman-Wright K; Stromblad S
Article: ONCOTARGET. 2015;6(32):33623-33635
Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells
Borbely G; Haldosen L-A; Dahlman-Wright K; Zhao C
Article: ONCOTARGET. 2015;6(10):7804-7814
AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer
Qiao Y; Shiue C-N; Zhu J; Zhuang T; Jonsson P; Wright APH; Zhao C; Dahlman-Wright K
Article: ONCOGENE. 2014;33(34):4340-4351
The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin C-Y; Qiao Y; Zendehdel K; Stroemblad S; Treuter E; Dahlman-Wright K
Article: CANCER RESEARCH. 2014;74(14):3983-3994
Genome-wide Profiling of AP-1-Regulated Transcription Provides Insights into the Invasiveness of Triple-Negative Breast Cancer
Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K
Article: BMC CANCER. 2013;13:441
Expression of activator protein-1 (AP-1) family members in breast cancer
Kharman-Biz A; Gao H; Ghiasvand R; Zhao C; Zendehdel K; Dahlman-Wright K
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2012;426(1):26-32
Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells
Putnik M; Zhao C; Gustafsson J-A; Dahlman-Wright K
Article: CARCINOGENESIS. 2012;33(9):1684-1691
Interplay between AP-1 and estrogen receptor in regulating gene expression and proliferation networks in breast cancer cells
Dahlman-Wright K; Qiao Y; Jonsson P; Gustafsson J-A; Williams C; Zhao C
Article: SHOCK. 2012;37(4):355-359
GENE EXPRESSION OF ESTROGEN RECEPTORS IN PBMC FROM PATIENTS WITH PUUMALA VIRUS INFECTION
Brundin P; Zhao C; Dahlman-Wright K; Ahlm C; Evengard B
Article: GENOME BIOLOGY. 2012;13(3):R24
The Transcription Factor Encyclopedia
Yusuf D; Butland SL; Swanson MI; Bolotin E; Ticoll A; Cheung WA; Zhang XYC; Dickman CTD; Fulton DL; Lim JS; Schnabl JM; Ramos OHP; Vasseur-Cognet M; de Leeuw CN; Simpson EM; Ryffel GU; Lam EW-F; Kist R; Wilson MSC; Marco-Ferreres R; Brosens JJ; Beccari LL; Bovolenta P; Benayoun BA; Monteiro LJ; Schwenen HDC; Grontved L; Wederell E; Mandrup S; Veitia RA; Chakravarthy H; Hoodless PA; Mancarelli MM; Torbett BE; Banham AH; Reddy SP; Cullum RL; Liedtke M; Tschan MP; Vaz M; Rizzino A; Zannini M; Frietze S; Farnham PJ; Eijkelenboom A; Brown PJ; Laperriere D; Leprince D; de Cristofaro T; Prince KL; Putker M; del Peso L; Camenisch G; Wenger RH; Mikula M; Rozendaal M; Mader S; Ostrowski J; Rhodes SJ; Van Rechem C; Boulay G; Olechnowicz SWZ; Breslin MB; Lan MS; Nanan KK; Wegner M; Hou J; Mullen RD; Colvin SC; Noy PJ; Webb CF; Witek ME; Ferrell S; Daniel JM; Park J; Waldman SA; Peet DJ; Taggart M; Jayaraman P-S; Karrich JJ; Blom B; Vesuna F; O'Geen H; Sun Y; Gronostajski RM; Woodcroft MW; Hough MR; Chen E; Europe-Finner GN; Karolczak-Bayatti M; Bailey J; Hankinson O; Raman V; LeBrun DP; Biswal S; Harvey CJ; DeBruyne JP; Hogenesch JB; Hevner RF; Heligon C; Luo XM; Blank MC; Millen KJ; Sharlin DS; Forrest D; Dahlman-Wright K; Zhao C; Mishima Y; Sinha S; Chakrabarti R; Portales-Casamar E; Sladek FM; Bradley PH; Wasserman WW
Article: PLOS ONE. 2010;5(12):e15594
Fatty Acids Derived from Royal Jelly Are Modulators of Estrogen Receptor Functions
Moutsatsou P; Papoutsi Z; Kassi E; Heldring N; Zhao C; Tsiapara A; Melliou E; Chrousos GP; Chinou I; Karshikoff A; Nilsson L; Dahlman-Wright K
Article: CURRENT OPINION IN PHARMACOLOGY. 2010;10(6):692-697
Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases
Faulds MH; Zhao C; Dahlman-Wright K
Article: PLOS ONE. 2010;5(11):e14085
Gene Expression Profiling and Chromatin Immunoprecipitation Identify DBN1, SETMAR and HIG2 as Direct Targets of SOX11 in Mantle Cell Lymphoma
Wang X; Bjoerklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
Article: CANCER RESEARCH. 2010;70(12):5174-5183
Genome-Wide Mapping of Estrogen Receptor-β-Binding Regions Reveals Extensive Cross-Talk with Transcription Factor Activator Protein-1
Zhao C; Gao H; Liu Y; Papoutsi Z; Jaffrey S; Gustafsson J-A; Dahlman-Wright K
Article: CANCER RESEARCH. 2010;70(3):1265-1274
RBCK1 Drives Breast Cancer Cell Proliferation by Promoting Transcription of Estrogen Receptor α and Cyclin B1
Gustafsson N; Zhao C; Gustafsson J-A; Dahlman-Wright K
Article: ENDOCRINE. 2009;36(2):224-232
Microarray analysis of altered gene expression in ERβ-overexpressing HEK293 cells
Zhao C; Putnik M; Gustafsson J-A; Dahlman-Wright K
Article: BMC GENETICS. 2009;10:55
Effects of two common polymorphisms in the 3′ untranslated regions of estrogen receptor β on mRNA stability and translatability
Putnik M; Zhao C; Gustafsson J-A; Dahlman-Wright K
Article: CANCER RESEARCH. 2009;69(15):6100-6106
Tumor Repressive Functions of Estrogen Receptor β in SW480 Colon Cancer Cells
Hartman J; Edvardsson K; Lindberg K; Zhao C; Williams C; Strom A; Gustafsson J-A
Article: JOURNAL OF MOLECULAR ENDOCRINOLOGY. 2009;43(1-2):65-72
Binding of estrogen receptor α/β heterodimers to chromatin in MCF-7 cells
Papoutsi Z; Zhao C; Putnik M; Gustafsson J-A; Dahlman-Wright K
Article: CANCER RESEARCH. 2007;67(8):3955-3962
Estrogen receptor β2 negatively regulates the transactivation of estrogen receptor α in human breast cancer cells
Zhao C; Matthews J; Tujague M; Wan J; Strom A; Toresson G; Lam EW-F; Cheng G; Gustafsson J-A; Dahlman-Wright K
Article: PHARMACOGENETICS AND GENOMICS. 2006;16(5):379-383
Functional characterization of a novel variant of estrogen receptor beta identified in screening of DNA derived from African Americans
Zhao C; Gustafsson J; Dahlman-Wright K
Article: BIOCHEMISTRY. 2005;44(22):7936-7944
Mouse estrogen receptor β isoforms exhibit differences in ligand selectivity and coactivator recruitment
Zhao CY; Toresson G; Xu L; Koehler KF; Gustafsson J; Dahlman-Wright K
Article: CARCINOGENESIS. 2004;25(11):2067-2073
Identification of a functional variant of estrogen receptor beta in an African population
Zhao CY; Xu L; Otsuki M; Toresson G; Koehler K; Pan-Hammarström Q; Hammarström L; Nilsson S; Gustafsson J; Dahlman-Wright K
Article: ONCOGENE. 2003;22(48):7600-7606
Expression of estrogen receptor β isoforms in normal breast epithelial cells and breast cancer:: regulation by methylation
Zhao CY; Lam EWF; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson J; Dahlman-Wright K
Article: BREAST CANCER RESEARCH AND TREATMENT. 2003;79(3):409-413
Polymorphisms in the estrogen receptor beta gene and risk of breast cancer:: no association
Försti A; Zhao CY; Israelsson E; Dahlman-Wright K; Gustafsson J; Hemminki K
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;103(5):671-675
Single nucleotide polymorphisms in the XPG gene:: Determination of role in DNA repair and breast cancer risk
Kumar R; Höglund L; Zhao C; Försti A; Snellman E; Hemminki K
Article: MUTAGENESIS. 2002;17(3):189-191
Measurement of cyclobutane thymidine dimers in melanocytic nevi and surrounding epidermis in human skin in situ
Wilms LC; Zhao C; Snellman E; Segerbäck D; Hemminki K
Article: CARCINOGENESIS. 2002;23(4):605-609
Demonstration of UV-dimers in human skin DNA in situ 3 weeks after exposure.
Hemminki K; Xu G; Kause L; Koulu LM; Zhao C; Jansen CT
Article: INTERNATIONAL JOURNAL OF CANCER. 2002;98(3):331-334
In situ repair of cyclobutane pyrimidine dimers in skin and melanocytic nevi of cutaneous melanoma patients.
Zhao C; Snellman E; Jansen CT; Hemminki K
Article: CARCINOGENESIS. 2002;23(2):307-310
The in vivo levels of DNA alkylation products in human lymphocytes are not age dependent: an assay of 7-methyl- and 7-(2-hydroxyethyl)-guanine DNA adducts.
Zhao C; Hemminki K
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2002;118(1):180-184
Ultraviolet photoproduct levels in melanocytic nevi and surrounding epidermis in human skin in situ.
Zhao C; Snellman E; Jansen CT; Hemminki K
Article: ENVIRONMENTAL AND MOLECULAR MUTAGENESIS. 2001;37(3):226-230
DNA adducts of 1,3-butadiene in humans: Relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points
Zhao C; Vodicka P; Sram RJ; Hemminki K
Article: BIOMARKERS. 2000;5(3):168-181
(32)P-postlabelling analysis of 1,3-butadiene-induced DNA adducts in vivo and in vitro.
Zhao C; Koskinen M; Hemminki K
Article: CARCINOGENESIS. 2000;21(1):107-111
Human DNA adducts of 1,3-butadiene, an important environmental carcinogen.
Zhao C; Vodicka P; Srám1 RJ; Hemminki K
Article: CHEMICAL RESEARCH IN TOXICOLOGY. 1999;12(10):979-984
Comparison of ³²P-postlabeling and high-resolution GC/MS in quantifying N7-(2-hydroxyethyl)guanine adducts
Eide I; Zhao CY; Kumar R; Hemminki K; Wu KY; Swenberg JA
Article: MUTATION RESEARCH - FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS. 1999;424(1-2):117-125
Endogenous and background DNA adducts by methylating and 2-hydroxyethylating agents.
Zhao C; Tyndyk M; Eide I; Hemminki K
Article: BIOMARKERS. 1998;3(4-5):327-334
Measurement of 7-methyl- and 7-(2-hydroxyethyl)guanine DNA adducts in white blood cells of smokers and non-smokers
Zhao CY; Kumar R; Hemminki K
Article: CARCINOGENESIS. 1997;18(11):2205-2208
DNA adducts in human nasal mucosa and white blood cells from smokers and non-smokers
Zhao CY; Georgellis A; Flato S; Palmberg L; Thunberg E; Hemminki K
Article: BIOMARKERS. 1997;2(6):355-360
Persistence of 7-(2-hydroxyethyl)guanine-DNA adducts in rats exposed to ethene by inhalation
Zhao CY; Kumar R; Zahlsen K; Sundmark HB; Hemminki K; Eide I
Visa fler

Alla övriga publikationer

Review: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2014;382(1):665-672
Estrogen receptor beta in breast cancer
Haldosen L-A; Zhao C; Dahlman-Wright K
Review: JOURNAL OF ENDOCRINOLOGY. 2012;212(1):3-12
The diversity of sex steroid action: regulation of metabolism by estrogen signaling
Faulds MH; Zhao C; Dahlman-Wright K; Gustafsson J-A
Review: JOURNAL OF BIOLOGICAL CHEMISTRY. 2010;285(51):39575-39579
Estrogen Signaling via Estrogen Receptor β
Zhao C; Dahlman-Wright K; Gustafsson J-A
Review: JOURNAL OF ENDOCRINOLOGY. 2010;204(3):233-240
Liver X receptor in cholesterol metabolism
Zhao C; Dahlman-Wright K
Review: NUCLEAR RECEPTOR SIGNALING. 2008;6:e003
Estrogen receptor beta: an overview and update.
Zhao C; Dahlman-Wright K; Gustafsson J-A
Letter: INTERNATIONAL JOURNAL OF CANCER. 2001;92(6):923-925
DNA adducts as a marker for cancer risk?
Hemminki K; Koskinen M; Zhao C
Published conference paper: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2000;32(3):264-275
Dna adducts, mutations, and cancer 2000.
Hemminki K; Koskinen M; Rajaniemi H; Zhao C
Thesis / dissertation: 2000
DNA adducts formed by ethene and butadiene : quantitative analysis in rats and humans
Zhao, Chunyan
Published conference paper: TOXICOLOGY LETTERS. 1998;102-103:591-594
32P-postlabelling of N6-adenine adducts of epoxybutanediol in vivo after 1,3-butadiene exposure.
Zhao C; Koskinen M; Hemminki K

Anställningar

Forskare, Medicin, Huddinge, Karolinska Institutet, 2024-

Examina och utbildning

Docent, Molekylär endokrinologi, Karolinska Institutet, 2011
MEDICINE DOKTORSEXAMEN, Institutionen för biovetenskaper och näringslära, Karolinska Institutet, 2000

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI